ALT-711 15mg X 60ml

ALT-711, also known as Alagebrium, is a drug candidate developed to break down advanced glycation end-product (AGE) cross-links in proteins, which contribute to age-related diseases like vascular stiffening, hypertension, and heart failure. It works by detaching these harmful bonds, aiming to restore tissue elasticity, improve arterial compliance, enhance cardiac function, and potentially treat complications from diabetes. While showing promise in animal and early human studies, particularly for cardiovascular stiffness, its widespread clinical success for public use has been limited, with research focusing on its mechanisms and potential.